Results 31 to 40 of about 172,093 (166)

Interstitial lung diseases in children

La Presse Médicale, 2020
Interstitial lung disease (ILD) in children (chILD) is a heterogeneous group of rare respiratory disorders that are mostly chronic and associated with high morbidity and mortality. The pathogenesis of the various chILD is complex and the diseases share common features of inflammatory and fibrotic changes of the lung parenchyma that impair gas exchanges.
Nadia, Nathan, Laura, Berdah, Céline, Delestrain, Chiara, Sileo, Annick, Clement   +4 more
openaire   +3 more sources

Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial

Trials, 2017
Background Fibrotic interstitial lung diseases (ILDs) are chronic and often progressive conditions resulting in substantial morbidity and mortality. Shortness of breath, a symptom often linked to oxygen desaturation on exertion, is tightly linked to ...
Dina Visca, Vicky Tsipouri, Letizia Mori, Ashi Firouzi, Sharon Fleming, Morag Farquhar, Elizabeth Leung, Toby M. Maher, Paul Cullinan, Nick Hopkinson, Athol U. Wells, Winston Banya, Jennifer A. Whitty, Huzaifa Adamali, Lisa G. Spencer, Piersante Sestini, Elisabetta A. Renzoni   +16 more
doaj   +1 more source

Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases

Frontiers in Medicine, 2023
Progressive fibrosing interstitial lung diseases (PF-ILDs) represent a group of conditions of both known and unknown origin which continue to worsen despite standard treatments, leading to respiratory failure and early mortality.
Stefan Cristian Stanel, Stefan Cristian Stanel, Pilar Rivera-Ortega   +2 more
doaj   +1 more source

Multidisciplinary-derived clinical score for accurate prediction of long-term mortality in fibrotic lung disease patients

European Journal of Medical Research
Background Idiopathic pulmonary fibrosis (IPF) stands out as one of the most aggressive forms of interstitial lung diseases (ILDs), currently without a definitive cure.
Yu-Wan Liao, Yi-Ming Chen, Ming-Cheng Liu, Yu-Cheng Wu, Chiann-Yi Hsu, Pin-Kuei Fu, Wen-Nan Huang, Yi-Hsing Chen   +7 more
doaj   +1 more source

Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis

BMC Pulmonary Medicine, 2017
Background Dyspnea is the hallmark symptom of pulmonary fibrosis. Supplemental oxygen (O2) is prescribed to many patients with pulmonary fibrosis in hopes of alleviating dyspnea and improving physical functioning.
Amy L. Olson, Bridget Graney, Susan Baird, Tara Churney, Kaitlin Fier, Marjorie Korn, Mark McCormick, David Sprunger, Thomas Vierzba, Frederick S. Wamboldt, Jeffrey J. Swigris   +10 more
doaj   +1 more source

Interstitial lung disease in newborns [PDF]

Seminars in Fetal and Neonatal Medicine, 2017
The term 'interstitial lung disease' (ILD) refers to a group of disorders involving both the airspaces and tissue compartments of the lung, and these disorders are more accurately termed diffuse lung diseases. Although rare, they are associated with significant morbidity and mortality, with the prognosis depending upon the specific diagnosis. The major
openaire   +2 more sources

Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis

Stem Cell Research & Therapy, 2018
Background Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease for which age is the most important risk factor. Different mechanisms associated with aging, including stem cell dysfunction, have been described to participate in the ...
Nayra Cárdenes, Diana Álvarez, Jacobo Sellarés, Yating Peng, Catherine Corey, Sophie Wecht, Seyed Mehdi Nouraie, Swaroop Shanker, John Sembrat, Marta Bueno, Sruti Shiva, Ana L. Mora, Mauricio Rojas   +12 more
doaj   +1 more source

Interstitial lung disease and diabetes

World Journal of Diabetes, 2020
Diabetes mellitus (DM) is a chronic metabolic disease and its prevalence has been steadily increasing all over the world. DM and its associated micro and macrovascular complications result in significant morbidity and mortality. The microvascular complications are usually manifested as retinopathy, neuropathy, nephropathy and macrovascular ...
Rajasurya, Venkat, Gunasekaran, Kulothungan, Surani, Salim   +2 more
openaire   +2 more sources

The lung microbiome in interstitial lung disease

Breathe
Interstitial lung disease (ILD) is a heterogeneous chronic form of lung disease. The pathogenesis of ILD is poorly understood and a common form of ILD, idiopathic pulmonary fibrosis (IPF) is associated with poor prognosis. There is evidence for substantial dysregulated immune responses in ILD.
Mikhail, Sheridan G., O'Dwyer, David N.
openaire   +2 more sources

Lung transplantation for interstitial lung disease

Breathe
Interstitial lung diseases (ILDs) are now the most common indication for lung transplant internationally. Given that many lung transplant candidates with idiopathic pulmonary fibrosis are older, referral to a pulmonary rehabilitation programme is important to help mitigate the adverse outcomes associated with frailty.
Ronan, Nicola J., Helly, Feargal, Murray, Michelle A.   +2 more
openaire   +2 more sources